NOVARTIS AG-REG (NOT.DE) Stock Earnings & Estimates
FRA:NOT - CH0012005267 - Common Stock
108.34 EUR
-0.66 (-0.61%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 43.375B -1.36% | 46.66B 7.57% | 51.722B 10.85% | 56.38B 9.01% | 57.783B 2.49% | 59.525B 3.01% | 61.563B 3.42% | 63.407B 3.00% | 64.871B 2.31% | 61.257B -5.57% | 56.233B -8.20% | |
| EBITDA YoY % growth | 17.387B 1.82% | 20.919B 20.31% | 20.919B | 22.66B 8.32% | 23.147B 2.15% | 23.969B 3.55% | 26.102B 8.90% | 27.177B 4.12% | 29.585B 8.86% | 23.232B -21.47% | 20.448B -11.98% | |
| EBIT YoY % growth | 10.206B -6.91% | 12.642B 23.87% | 16.32B 29.09% | 20.983B 28.57% | 21.437B 2.16% | 22.615B 5.50% | 24.876B 10.00% | 25.678B 3.22% | 26.065B 1.51% | 25.504B -2.15% | 22.87B -10.33% | |
| Operating Margin | 23.53% | 27.09% | 31.55% | 37.22% | 37.10% | 37.99% | 40.41% | 40.50% | 40.18% | 41.63% | 40.67% | |
| EPS YoY % growth | 6.12 -2.70% | 6.90 12.75% | 7.81 13.19% | 9.08 16.29% | 9.44 3.96% | 10.19 7.89% | 10.72 5.22% | 11.12 3.76% | 11.58 4.10% | 12.04 3.96% | 10.91 -9.36% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 2.26 9.82% | 1.99 0.45% | 2.31 1.51% | 2.24 -7.61% | 2.30 1.85% | 1.97 -1.12% |
| Revenue Q2Q % growth | 14.168B 7.56% | 14.049B 6.81% | 13.127B -0.80% | 13.413B -4.56% | 13.632B -3.78% | 13.398B -4.63% |
| EBITDA Q2Q % growth | 5.137B -41.54% | 4.459B -55.97% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 5.374B 23.65% | 4.671B 15.08% | 5.472B 14.33% | 5.324B 3.28% | 5.447B 1.36% | 4.66B -0.24% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 2.42 22.84% | 2.41 | 0.01 | 0.61% |
| Q1 2025 Q2Q % growth | 2.28 26.67% | 2.14 | 0.14 | 6.59% |
| Q4 2024 Q2Q % growth | 1.98 29.41% | 1.87 | 0.11 | 6.06% |
| Q3 2024 Q2Q % growth | 2.06 12.57% | 1.99 | 0.07 | 3.78% |
| Q2 2024 Q2Q % growth | 1.97 7.65% | 1.91 | 0.06 | 3.24% |
| Q1 2024 Q2Q % growth | 1.80 5.26% | 1.71 | 0.09 | 5.40% |
| Q4 2023 Q2Q % growth | 1.53 0.66% | 1.65 | -0.12 | -7.44% |
| Q3 2023 Q2Q % growth | 1.83 15.82% | 1.76 | 0.07 | 3.88% |
| Q2 2023 Q2Q % growth | 1.83 17.31% | 1.73 | 0.10 | 5.73% |
| Q1 2023 Q2Q % growth | 1.71 17.12% | 1.56 | 0.15 | 9.32% |
| Q4 2022 Q2Q % growth | 1.52 8.57% | 1.43 | 0.09 | 6.28% |
| Q3 2022 Q2Q % growth | 1.58 -7.60% | 1.58 | 0.00 | -0.02% |
| Q2 2022 Q2Q % growth | 1.56 -6.02% | 1.53 | 0.03 | 2.08% |
| Q1 2022 Q2Q % growth | 1.46 -3.95% | 1.47 | -0.01 | -0.62% |
| Q4 2021 Q2Q % growth | 1.40 4.48% | 1.45 | -0.05 | -3.12% |
| Q3 2021 Q2Q % growth | 1.71 12.50% | 1.68 | 0.03 | 1.93% |
| Q2 2021 Q2Q % growth | 1.66 22.06% | 1.57 | 0.09 | 5.67% |
| Q1 2021 Q2Q % growth | 1.52 -2.56% | 1.59 | -0.07 | -4.32% |
| Q4 2020 Q2Q % growth | 1.34 1.52% | 1.40 | -0.06 | -4.21% |
| Q3 2020 Q2Q % growth | 1.52 7.80% | 1.48 | 0.04 | 2.60% |
| Q2 2020 Q2Q % growth | 1.36 1.49% | 1.35 | 0.01 | 0.78% |
| Q1 2020 Q2Q % growth | 1.56 28.93% | 1.42 | 0.14 | 9.89% |
| Q4 2019 Q2Q % growth | 1.32 | 1.33 | -0.01 | -0.40% |
| Q3 2019 Q2Q % growth | 1.41 | 1.37 | 0.04 | 2.86% |
| Q2 2019 Q2Q % growth | 1.34 | 1.25 | 0.09 | 7.40% |
| Q1 2019 Q2Q % growth | 1.21 | 1.17 | 0.04 | 3.42% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 14.054B 9.18% | 14.465B | -411M | -2.84% |
| Q1 2025 Q2Q % growth | 13.233B 9.18% | 13.384B | -151M | -1.13% |
| Q4 2024 Q2Q % growth | 13.153B 11.69% | 13.051B | 102M | 0.78% |
| Q3 2024 Q2Q % growth | 13.172B 8.93% | 12.994B | 178M | 1.37% |
| Q2 2024 Q2Q % growth | 12.872B 9.60% | 12.61B | 262M | 2.08% |
| Q1 2024 Q2Q % growth | 12.12B 9.71% | 11.709B | 411M | 3.51% |
| Q4 2023 Q2Q % growth | 11.776B 8.24% | 11.996B | -220M | -1.83% |
| Q3 2023 Q2Q % growth | 12.092B 12.14% | 12.001B | 91M | 0.76% |
| Q2 2023 Q2Q % growth | 11.745B -45.91% | 13.518B | -1.773B | -13.12% |
| Q1 2023 Q2Q % growth | 11.047B -14.64% | 12.877B | -1.83B | -14.21% |
| Q4 2022 Q2Q % growth | 10.88B 135.55% | 13.285B | -2.405B | -18.10% |
| Q3 2022 Q2Q % growth | 10.783B -19.33% | 13.106B | -2.323B | -17.72% |
| Q2 2022 Q2Q % growth | 21.712B 63.32% | 13.109B | 8.603B | 65.63% |
| Q1 2022 Q2Q % growth | 1.95% | 12.942B | % | |
| Q4 2021 Q2Q % growth | 4.619B -64.55% | 13.616B | -8.997B | -66.08% |
| Q3 2021 Q2Q % growth | 13.367B 6.61% | 13.285B | 82M | 0.62% |
| Q2 2021 Q2Q % growth | 13.294B 14.39% | 12.773B | 521M | 4.08% |
| Q1 2021 Q2Q % growth | 12.694B -0.11% | 12.771B | -77M | -0.60% |
| Q4 2020 Q2Q % growth | 13.03B 2.47% | 13.147B | -117M | -0.89% |
| Q3 2020 Q2Q % growth | 12.538B 0.45% | 12.818B | -280M | -2.18% |
| Q2 2020 Q2Q % growth | 11.622B -3.34% | 12.13B | -508M | -4.19% |
| Q1 2020 Q2Q % growth | 12.708B 11.45% | 12.249B | 459M | 3.75% |
| Q4 2019 Q2Q % growth | 12.716B | 12.517B | 199M | 1.59% |
| Q3 2019 Q2Q % growth | 12.482B | 12.065B | 417M | 3.46% |
| Q2 2019 Q2Q % growth | 12.024B | 11.752B | 272M | 2.31% |
| Q1 2019 Q2Q % growth | 11.402B | 11.601B | -199M | -1.72% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 4.67% | 4.47% | 4.47% |
| Revenue | 0% | 6.7% | 0.05% | 1.67% |